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Abstract: Diet and chronic inflammation of the colon have been suggested to be risk factors in the
development of colorectal cancer (CRC). The possible link between inflammatory potential of diet,
measured through the Dietary Inflammatory Index (DII®), and CRC has been investigated in several
populations across the world. The aim of this study was to conduct a meta-analysis on studies
exploring this association. Data from nine studies were eligible, of which five were case-control
and four were cohort studies. Results from meta-analysis showed a positive association between
increasing DII scores, indicating a pro-inflammatory diet, and CRC. Individuals in the highest versus
the lowest (reference) DII category showed an overall 40% increased risk of CRC with moderate
evidence of heterogeneity [relative risk (RR) = 1.40, 95% confidence interval (CI): 1.26, 1.55; I2 = 69%,
p < 0.001]. When analyzed as a continuous variable, results showed an increased risk of CRC of 7%
for a 1-point increase in the DII score. Results remained unchanged when analyses were restricted
to the four prospective studies. Results of our meta-analysis support the importance of adopting
a healthier anti-inflammatory diet in preventing CRC. These results further substantiate the utility of
DII as tool to characterize the inflammatory potential of diet and to predict CRC.
Keywords: diet; cytokines; nutrition; inflammation; epidemiology; dietary inflammatory index;
colorectal cancer; meta-analysis
1. Introduction
Colorectal cancer (CRC) is the third most common form of cancer worldwide and is one of the
leading causes of cancer-related deaths [1]. Incidence and mortality rates of CRC vary widely with
higher incidence rates in developed nations and lower incidence rates in Asia, Africa, and most Latin
American countries [2]. Inflammation typically occurs as part of the body’s normal response to tissue
insult/injury [3,4]. Chronic inflammation is a persistent condition in which tissue destruction and
repair occur simultaneously [5,6], involving continuous recruitment of pro-inflammatory cytokines
(associated with increased blood flow to the injured tissue, due to histamine released by damaged
mast cells) [3]. Increased levels of these cytokines also are believed to be associated with CRC [7–9].
Furthermore, some research suggests a direct association between specific dietary components and
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inflammation [10–13]. Various dietary components may be involved in the development of CRC [14].
The 2012 American Institute for Cancer Research/World Cancer Research Fund Continuous Update
Project (CUP) reported that consumption of red and processed meat, which are pro-inflammatory,
is associated with an increased risk of CRC [14]. Conversely, the consumption of dietary fiber,
which is anti-inflammatory, is inversely associated with risk of CRC [14]. Furthermore, other dietary
components, such as tea and coffee, which we have found to be anti-inflammatory, have demonstrated
various health benefits , including lower cancer incidence [15,16] and mortality [17,18]. Moreover,
comprehensive investigations on whole dietary patterns have indicated that unhealthy dietary patterns
are associated with higher risk of CRC and adenoma, while healthy diets are associated with lower
risk [19,20].
In response to the absence of an instrument that could summarize diets’ ability to influence
inflammatory processes, in 2009 researchers at the University of South Carolina developed the
first Dietary Inflammatory Index, which was created based on literature published on diet and
inflammation through 2007 [21]. In 2014 the new refined and improved Dietary Inflammatory
Index (DII®) was based on literature published on diet and inflammation through 2010 [22]. The
DII categorizes individuals’ diets according to their inflammatory potential on a continuum from
maximally pro-inflammatory to maximally anti-inflammatory. A higher DII score indicates a more
pro-inflammatory diet, whereas a lower DII score represents a more anti-inflammatory diet. The
DII is composed of 45 food parameters, out of which 36 are anti-inflammatory. These include: fiber,
alcohol, monounsaturated fatty acids, polyunsaturated fatty acids, omega 3, omega 6, niacin, thiamin,
riboflavin, vitamin B6, B12, zinc, magnesium, selenium, vitamin A, vitamin C, vitamin D, vitamin
E, folic acid, beta carotene, anthocyanidins, flavan3ols, flavonols, flavanones, flavones, isoflavones,
garlic, ginger, onions, thyme, oregano, saffron, turmeric, rosemary, eugenol, caffeine, and tea. The
remaining 9 are pro-inflammatory components: energy, carbohydrates, proteins, total fat, trans fat,
cholesterol, vitamin B12, saturated fatty acids and iron. As a rule, foods that have low DII scores
tend to be flavorful, colorful, nutrient-dense, and calorie-sparse. By contrast, those foods that have
high DII scores tend to be flavorless (even though they may have a strong taste, such as sweet), are
white or colorless, nutrient-sparse and calorie-dense. The DII was found to predict changes in high
sensitivity-C-reactive protein (hs-CRP) in the Seasonal Variation in Blood Cholesterol Study [21,23].
Subsequently, the DII has been used in several studies from around the world to test the effect of
diet-associated inflammation on inflammation markers such as CRP, interleukin (IL)-6, and (tumor
necrosis factor) and TNF-α-R2 [23–30]. In the Seasonal Variation of Blood Cholesterol Study, higher
DII scores were associated with values of hs-CRP > 3 mg/L [odds ratio (OR) = 1.08; 95% confidence
interval (CI): 1.01, 1.16, p = 0.035 for the 24 hour recall (24 HR) subset; and OR = 1.10; 95% CI:
1.02, 1.19, p = 0.015 for the 7-Day Dietary Recall] [23]; in the Women’s Health Initiative, the DII
was associated with the four biomarkers with beta estimates comparing the highest with lowest DII
quintiles as follows: Interleukin-6: 1.26 (1.15–1.38), p trend < 0.0001; tumor necrosis factor alpha receptor
2: 81.43 (19.15–143.71), p trend = 0.004; dichotomized hs-CRP (odds ratio for higher vs. lower hs-CRP):
1.30 (0.97–1.67), p trend = 0.34; and the combined inflammatory biomarker score: 0.26 (0.12–0.40),
p trend = 0.0001 [24]. Additionally, the DII has been linked to various health outcomes including
cancer incidence [31–33]; all-cause, cardiovascular and cancer-specific mortality [34–36]; respiratory
conditions such as asthma [28,37]; and cognitive disorders [38,39]. The most consistent results have
been observed with CRC, with nine studies published exploring this association [40–48]. The current
meta-analysis aimed to investigate the cumulative association between the inflammatory potential of
diet, as estimated by the DII score, and CRC risk based on the results from nine previous studies.
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2. Methods
2.1. Search Strategy and Study Selection
Literature databases including PubMed, SCOPUS, and EMBASE were searched from beginning
through July 2017. Relevant keywords related to the DII were searched in combination with keywords
related to CRC {[(dietary inflammatory index OR inflammatory diet OR anti-inflammatory diet OR
dietary score) AND (colorectal OR colon OR rectal OR rectum)] AND (cancer OR carcinoma OR
neoplasm)}. Reference lists of retrieved articles were manually searched by two researchers (G.G.
and S.N.). The literature search was limited to English. If more than one article was published using
the same cohort, the most recent article with the longest follow-up period was considered. Studies
included in this systematic review met all of the following inclusion criteria: (i) focused on humans and
had a case-control or a prospective study design; and (ii) evaluated the risk or association between the
DII and CRC. The two investigators independently assessed articles for compliance with the inclusion
and exclusion criteria and resolved disagreements through consensus.
2.2. Data Extraction
The following information was extracted from each study: (i) name of the first author; (ii) year of
publication; (iii) study cohort or name; (iv) country; (v) number of participants; (vi) sex of participants;
(vii) age range or mean age of the study population at baseline; (viii) follow-up period; (ix) endpoints
and cases; (x) measures of risk [hazard ratios (HRs)] or association [odds ratios (ORs)] with 95%
confidence intervals (CIs) for the highest versus the lowest category of exposure and for 1-point
increase of the DII score (when available); and (xi) covariates used for adjustment.
The quality of observational studies was assessed according to the Newcastle-Ottawa Quality
Assessment Scale [49], consisting of three parameters of quality: selection (four points), comparability
(two points), and outcome (three points), with a score of seven or more points reflecting high quality.
2.3. Statistical Analysis
In this meta-analysis, ORs and HRs were deemed equivalent to relative risks (RRs) [50]. Random-
and fixed-effects models were used to calculate pooled RRs with 95% CIs of colorectal cancer for
the highest compared to the lowest category of exposure and for a 1-point increase of the DII score.
Risk estimates of CRC for 1-point increase of the score (continuous) also were estimated in studies
not reporting the measure, but providing sufficient data to estimate it. Heterogeneity was assessed
by using the Q test and I2 statistic. The significance of the Q test was defined as p < 0.10. The I2
statistic represents the amount of total variation that could be attributed to heterogeneity. I2 values
≤25%, ≤50%, ≤75% and >75% indicated no, little, moderate, and high heterogeneity, respectively.
A sensitivity analysis was conducted by excluding one study at a time in order to assess the stability of
results. Subgroup analyses were conducted by tumor localization (colon, rectum), sex, geographical
region [North America (n = 5), Europe (n = 2)], and adjustment for smoking, BMI, physical activity
and non-steroidal anti-inflammatory drug (NSAID) use. Publication bias was assessed by visual
observation of funnel plots. All analyses were performed with Review Manager (RevMan) version 5.2
(The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark).
3. Results
The relevance of studies was assessed with a hierarchical approach on the basis of title, abstract,
and the full manuscript. The full process of identification and selection of studies is shown in Figure 1.
The search strategy identified 1,003 studies, of which 925 were excluded after review of title, and 66 on
the basis of abstract (Figure 1). Of the 12 publications selected, 3 were not included for the following
reasons: (1) the article evaluated the association between different dietary score and CRC; (2) the study
was a systematic review (and therefore did not present any new finding).
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Figure 1. Flow chart and process selection of relevant studies exploring the association between 
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cancer available for the present meta-analysis.  
Table 1 shows the information extracted from all nine studies included. Five studies had a case-
control design [40,44,46–48], which comprised 4000 cases and 7288 controls. Four studies were 
prospective cohorts [41–43,45], which comprised 715,088 participants and 14,888 incident cases of 
colorectal cancer; cohorts included the Iowa Women’s Health Study (IWHS), the Women’s Health 
Initiative (WHI), The National Institutes of Health–American Association of Retired Persons (NIH-
AARP) Diet and Health Study, and the Multiethnic Cohort (MEC). All the studies included covariates 
that may have significant influence on colorectal cancer, such as age, sex (when not analyzed 
separately), BMI, education, physical activity, and smoking status. The comprehensive group of 
covariates used for adjustments are described in Table 1.
Figure 1. Flow chart and process selection of relevant studies exploring the association between Dietary
Inflammatory Index (DII) and risk of colorectal, colon and rectal cancer.
The nine studies s lected included a total of 881,612 indivi uals and 18,88 cases of c lorectal
cancer available for the pr sent meta-an lysis.
Table 1 shows the information extracted from all i t i included. Five studies h d
a case-control design [ 0, 4,46–48], w ich comprised 4 00 ca es and 7288 controls. Four studies
were prospective c horts [41– 3,45], w i h comprised 715,088 participants and 14,888 incident
cases of colore tal can er; cohorts included the Iowa Women’s Health Study (IWHS), the Women’s
Health Initiative (WHI), The National Institutes of Health–American Associati n of Retired Persons
(NIH- ARP) Diet and Health Study, and the Multiethnic Cohort (MEC). All the tudies included
covari tes that may have significa t influ nce on c lorectal cancer, as age, sex (when not analyzed
separately), BMI, education, physical activity, and smoking status. The comprehensive group of
covariates used for adjustments are described in Table 1.
Nutrients 2017, 9, 1043 5 of 17
Table 1. Characteristics of studies included in the meta-analysis.
















Females, 62 ± 4 34,703 1636 19.6 37
Age, BMI, smoking status, pack-years
of smoking, education, hormone
replacement therapy use, total energy








Age: 62 ± 5.4
489,422 6944 9.1 35
Age, smoking status, BMI,
self-reported diabetes, energy intake,










190,963 4388 20 28
Age, sex, BMI, race, self-reported
previous diagnosis of diabetes,
asthma, and heart attack; use of
supplements; smoking status; family
history of colon cancer; education;
hormone (i.e., estrogen or






Age: 50–79 152,536 1920 11.3 32
Age, total energy intake, body mass
index, race/ethnicity, physical activity,
educational level, smoking status,
family history of colorectal cancer,
hypertension, diabetes, arthritis,
history of colonoscopy, history of
occult blood tests, NSAID use,
category and duration of estrogen use,
category and duration of estrogen &
progesterone use, dietary modification
trial arm, hormone therapy trial arm
and calcium and vitamin trial arm
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Table 1. Cont.












2015 [48] Case-control Italy
Both males and
females.
Age: Case-60 ± 10
Controls-56 ± 11
4154 controls 1953 - 31
Age, sex, study center, education, BMI,
alcohol consumption, physical activity,
history of colorectal cancer, and
energy intake
Zamora-Ros et
al. 2015 [44] Case-control Spain
Both males and
females.
Age: 65.8 ± 12
401 controls 424 - 33
Age, sex, total energy intake, BMI,
first-degree family history of CRC,
physical activity, tobacco use, and
medication use (aspirin and NSAID)
Cho et al. 2016
[46] Case-control South Korea
Both males and
females.
Age: Cases = 56.6
Control = 56.1
1846 controls 923 - 36
Age, sex, BMI, education, family
history of colorectal cancer, physical
activity, and total energy intake.
Shivappa et al.
2017 [40] Case-control Jordan
Both males and
females.
Age: Cases: 52 ± 11
Controls: 54 ± 12
202 controls 153 - 18
Age, sex, education, physical activity,
body mass index, smoking, and family
history of colorectal cancer.
Sharma et al.
2017 [47] Case-control Canada
Both males and
females.
Age: Cases: 62 ± 9
Controls: 60 ± 9
685 controls 547 - 29
Age, sex, BMI, physical activity,
cholesterol level, triglycerides, family
history of CRC, polyps, diabetes,
history of colon screening, smoking,
alcohol consumption, regular use of
NSAIDs, and reported HRT,
females only.
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Individuals in the highest versus the lowest (reference) DII category of exposure had an overall
40% increased risk of colorectal cancer with moderate evidence of heterogeneity (RR = 1.40, 95% CI:
1.26, 1.55; I2 = 69%, p < 0.001; Figure 2). Funnel plot results indicate that case-control studies generally
reported higher risk estimates (Figure 3A). Both heterogeneity and funnel plot results (used to evaluate
risk of publication bias) were driven by case-control studies (Figures 2 and 3B). However, analysis
restricted to prospective cohorts alone showed essentially unchanged risk estimates, with only minor
evidence of heterogeneity and no evidence of publication bias (RR = 1.24, 95% CI: 1.15, 1.35; I2 = 50%,
p = 0.08; Figures 2 and 3C). When using a fixed-effect model, risk estimates were essentially the same
for colorectal cancer (RR = 1.32, 95% CI: 1.26, 1.39; I2 = 69%, p < 0.001), and in separate analysis for
prospective cohorts (RR = 1.26, 95% CI: 1.19, 1.33; I2 = 50%, p = 0.08) and case-control studies (RR = 1.68,
95% CI: 1.49, 1.90; I2 = 42%, p = 0.11). Subgroup analyses showed no differences between any of the
groups investigated (Table 2).
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Table 2. S b r a al s s f st ies re orti ris of colorectal, c l a rectal cancer for the
highest versus lo est (reference) category of dietary inflammatory index (DI ).
Subgroup No. of Data ets(No. of Studies) R (95% CI) I
2 (%) Pheterog neity
Colorectal
Total 13 (9) 1.40 (1.26, 1.55) 69% 0.0001
Study design
Prospective 6 (4) 1.24 (1.15, 1.35) 50% 0.08
Case-control 7 (5) 1.73 (1.46, 2.05) 42% 0.11
Gender
Men 4 (4) 1.51 (1.29, 1.75) 68% 0.02
Women 6 (6) 1.25 (1.10, 1.41) 61% 0.02
Geographical location
North America 7 (5) 1.26 (1.16, 1.36) 50% 0.06
Eur pe 3 (2) 1.57 (1.19, 2.07) 61% 0.08
Asia 3 (2) 1.97 (1.57, 2.49) 9% 0.33
Adjustment for smoking
No 4 (2) 1.74 (1.34, 2.25) 69% 0.02
Yes 9 (7) 1.28 (1.18, 1.40) 52% 0.03
Adjustment for BMI
No 1 (1) 1.65 (1.13, 2.42) NA NA
Yes 12 (8) 1.39 (1.25, 1.54) 70% 0.0001
Adjustment for physical
activity
No 3 (2) 1.22 (1.12, 1.32) 0% 0.55
Yes 10 (7) 1.51 (1.31, 1.74) 70% 0.00 4
Adjustment for NSAID
No 8 (5) 1.50 (1.28, 1.75) 76% 0.0002
Yes 5 (4) 1.25 (1.15, 1.37) 21% 0.28
Colon
Total 10 (7) 1.38 (1.23, 1.55) 61% 0.006
Study design
Pr spective 5 (4) 1.25 (1.16, 1.35) 11% 0.34
Case-control 5 (3) 1.70 (1.29, 2.24) 62% 0.03
Gender
Men 3 (3) 1.58 (1.36, 1.83) 0% 0.71
Women 5 (5) 1.27 (1.10, 1.48) 51% 0.09
Geographical location
North America 5 (4) 1.25 (1.16, 1.35) 11% 0.34
Europe 3 (2) 1.56 (1.06, 2.29) 71% 0.03
Asia 2 (1) 1.97 (1.34, 2.90) 39% 0.20
Nutrients 2017, 9, 1043 9 of 17
Table 2. Cont.
Subgroup No. of Datasets(No. of Studies) RR (95% CI) I
2 (%) Pheterogeneity
Adjustment for smoking
No 4 (2) 1.62 (1.20, 2.19) 66% 0.03
Yes 6 (5) 1.29 (1.16, 1.43) 46% 0.10
Adjustment for BMI
No 0 (0) NA NA NA
Yes 10 (7) 1.38 (1.23, 1.55) 61% 0.006
Adjustment for physical
activity
No 2 (2) 1.20 (1.10, 1.31) 0% 0.94
Yes 8 (5) 1.48 (1.27, 1.72) 59% 0.02
Adjustment for NSAID
No 7 (4) 1.43 (1.23, 1.66) 58% 0.03
Yes 3 (3) 1.29 (1.07, 1.56) 62% 0.07
Rectal
Total 10 (7) 1.35 (1.18, 1.56) 48% 0.04
Study design
Prospective 5 (4) 1.23 (1.03, 1.47) 54% 0.07
Case-control 5 (3) 1.55 (1.30, 1.85) 7% 0.36
Gender
Men 3 (3) 1.56 (1.35, 1.81) 0% 0.75
Women 5 (5) 1.28 (0.97, 1.69) 59% 0.05
Geographical location
North America 5 (4) 1.23 (1.03, 1.47) 54% 0.07
Europe 3 (2) 1.41 (1.15, 1.73) 0% 0.72
Asia 2 (1) 1.90 (1.41, 2.56) 3% 0.31
Adjustment for smoking
No 4 (2) 1.60 (1.34, 1.91) 4% 0.37
Yes 6 (5) 1.22 (1.04, 1.44) 43% 0.12
Adjustment for BMI
No 0 (0) NA NA NA
Yes 10 (7) 1.35 (1.18, 1.56) 48% 0.04
Adjustment for physical
activity
No 2 (2) 1.22 (1.03, 1.43) 0% 0.97
Yes 8 (5) 1.40 (1.17, 1.68) 54% 0.03
Adjustment for NSAID
No 7 (4) 1.43 (1.18, 1.73) 58% 0.03
Yes 3 (3) 1.21 (1.04, 1.41) 0% 0.96
The analysis considering the DII score as a continuous variable showed an increased risk of
colorectal cancer of 7% for each 1-point increase of the score, despite the analysis being affected by
similar limitations as the previous studies, such as high heterogeneity (Figure 4) and evidence of
publication bias based on the funnel plot (Figure 5A). When considering only prospective studies, the
association between a 1-point increase of the DII score and risk of colorectal cancer was significant, yet
with moderate heterogeneity between results (RR = 1.03, 95% CI: 1.02, 1.04; I2 = 58%, p = 0.03; Figure 4)
but no evidence of publication bias at funnel plot (Figure 5C).
The analyses of separate datasets by tumor location showed similar risk of both colon and rectal
cancer for the highest versus the lowest (reference) DII category of exposure, with similar characteristics
reported for the general analysis (Figures 6 and 7).
Nutrients 2017, 9, 1043 10 of 17
Nutrients 2017, 9, 1043 4 of 17 
 
 
Figure 4. Forest plot of summary relative risks (RRs) of colorectal cancer for a one-point increase of 
Dietary Inflammatory Index (DII), for case-control, prospective and all studies. 
 
 
Figure 4. Forest plot of summary relative risks (RRs) of colorectal cancer for a one-point increase of
Dietary Inflammatory Index (DII), for case-control, prospective and all studies.
utrients 2017, 9, 1043 4 of 17 
 
 
Figure 4. Forest plot of su ary relative risks ( s) of colorectal cancer for a one-point increase of 
ietary Infla atory Index ( II), for case-control, prospective and all studies. 
 
 
Figure 5. Funnel plots for colorectal cancer risk of a one-point increase of Dietary Inflammatory Index
(DII): (a) case-control, (b) prospective, and (c) total studies.
Nutrients 2017, 9, 1043 11 of 17
Nutrients 2017, 9, 1043 5 of 17 
 
Figure 5. Funnel plots for colorectal cancer risk of a one-point increase of Dietary Inflammatory Index 
(DII): (a) case-control, (b) prospective, and (c) total studies. 
The analyses of separate datasets by tumor location showed similar risk of both colon and rectal 
cancer for the highest versus the lowest (reference) DII category of exposure, with similar 
characteristics reported for the general analysis (Figures 6 and 7). 
 
Figure 6. Forest plot of summary relative risks (RRs) of colon and rectal cancer for the highest versus 
lowest (reference) category of Dietary Inflammatory Index (DII). 
 
Figure 7. Funnel plots for colon and rectal cancer risk of the highest versus lowest (reference) category 
of Dietary Inflammatory Index (DII): (a) colon and (b) rectal. 
4. Discussion 
Results from this meta-analysis of nine studies that have examined the association between 
inflammatory potential of diet, as measured by the DII, and CRC, showed strong evidence of positive 
association between the DII and CRC. This persisted across tumor location. Therefore, limiting 
consumption of pro-inflammatory foods, such as red meat, and increasing consumption of anti-
Figure 6. Forest plot of summary relative ris s ( t l ca cer for the highest versus
lowest (ref rence) category of Dietary Inflammatory In e ( .
Figure 7. Fun el plots for colon and rectal i est versus lowest (reference) category
of Dietary Inflam atory Index (DI ): (a) colon and ( ) rect l.
4. Discussion
Results from this meta-analysis of nine studies that have exa ined the association between
inflam atory potential of diet, as measured by the DII, and CRC, showed strong evidence of
positive association between the DII and CRC. This persisted across tumor location. Therefore,
limiting consumption of pro-inflammatory foods, such as red meat, and increasing consumption of
anti-inflammatory components, like fruits and vegetables, may play an important role in reducing
the risk of CRC. The DII score is calculated from several components and important among them
are polyphenols such as flavonoids. Isoflavones, flavanol, flavan-3-ol, anthocyanidins, flavones and
flavanones which form the six major groups of flavonoids are included in the DII calculation and all of
these are anti-inflammatory and therefore have negative inflammatory effect scores [22].
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The DII is a literature-derived population-based dietary index developed specifically to measure
the inflammatory potential of individuals’ overall diet across varying populations and dietary
assessment methods [30]. There are other dietary indices that exist, such as The Healthy Eating Index
(HEI) [51], Alternate Healthy Eating Index (AHEI) [52], Dietary Approaches to Stop Hypertension
Score (DASH) [53] and Mediterranean Diet Score (MDS) [54]; and these indices have been examined
with CRC as outcome in the past [55,56]. All of these indices represent a dietary scoring pattern that
represents healthfulness of the diet. However, none was specifically developed to assess the diet’s
inflammatory potential. Another advantage of DII is that it is grounded in the peer-reviewed literature
on diet and inflammation and is not dependent on a single study or a few studies within the same or
similar populations. Rather, it is based on findings from nearly 2000 articles focusing on laboratory and
human studies—from all over the world, employing different study designs and dietary assessment
methods. Articles were scored based on the direction of association observed in the article, for example,
if in an article garlic significantly reduced levels of CRP then the article would get a score of -1; these
articles were then weighted based on the study design. Human studies were given more weight, and
clinical trials were assigned the maximum weight of 10. The complete description on the design and
development of DII is described in the DII development paper [22]. Findings from the Energy Balance
Study indicated that the DII score was negatively correlated with the HEI-2010 (r = −0.65, p < 0.01),
AHEI (r = −0.55, p < 0.01), and the DASH (r = −0.52, p < 0.01) [57] and in the Melbourne Collaborative
Cohort Study, an inverse correlation was observed between the DII and MDS (r = −0.45, p < 0.01) [58].
Apart from showing a consistent association between DII and CRC, the DII also was successfully
validated with inflammatory markers in several studies across different populations [24,28,29,59,60].
This suggests that the DII represents unique aspects of diet that go beyond what constitutes a generally
healthy diet by capturing the specific effect of inflammation compared to other dietary indices. These
results provide evidence that the DII is unique in its ability to relate specifically to the core issue of
chronic inflammation.
There are several theories to explain the association between the DII and CRC risk; one of the most
commonly considered is the effect of pro-inflammatory diet on insulin resistance through increasing
systemic inflammation [61]. Another theory suggests the role of diet on local inflammation and
oxidation in the colon, which results in focal proliferation and mutagenesis [62]. On the other hand,
antioxidant compounds contained in key foods (i.e., fruits, vegetables, coffee, tea, etc.) may exert
anti-inflammatory effects, especially locally through the action of local microbiota [63]. Although, we
have observed strong evidence of association between DII scores and CRC, two studies examining
the association between DII scores and the prevalence or recurrence of colorectal adenoma, which is a
precursor of CRC, have produced equivocal results. One, conducted in the in the screening arm of
the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, produced positive results,
primarily in men [64]. The other, based on data from the Wheat Bran Fiber (WBF) and Ursodeoxycholic
Acid (UDCA) Phase III clinical trials, produced null results [65]. Although colorectal adenoma is a risk
factor for CRC, most adenomas will not undergo malignant transformation [66–68]. More studies are
warranted to further understand this association.
Dietary factors can be related to CRC through mechanisms other than inflammation. For example,
consumption of red and processed meat increases the risk of CRC through increased levels of the
haem iron content [69], N-nitroso compounds formed during the processing of meat [70], of polycyclic
aromatic hydrocarbons and heterocyclic aromatic amines from cooking meat at high temperatures [71].
On the other hand, higher fibre intake is believed to be related to a lower risk of colorectal cancer via
increase stool bulk, increase stool transit time, and dilute faecal carcinogens [72]. We have looked at
the relative effects of the DII score versus other indices such as the healthy eating Index. Usually about
25 to 50% of the variability in one index is explained by the DII [57,73]. So, there clearly are other; that
is, not inflammation-related, mechanisms that are operative. It is important to note that the DII would
encompass the effect of haem iron, because iron is a pro-inflammatory component of the DII. Factors
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related to the other effects of fiber are, indeed, related to inflammation. These other mechanisms, along
with inflammation, may exacerbate the effect of diet on CRC.
This meta-analysis had some limitations. First, DII score for all the studies was based on
self-reports collected from food frequency questionnaires, which are not error-free. We suspect
that self-assessments using these instruments in case-control studies are encumbered by recall bias [74],
which can lead to a potential misclassification of the exposure. Even in prospective studies such reports
may be subject to response set biases [75,76]. Second, DII score was estimated at baseline and diets
might change during study follow-up. However, adult dietary habits seem to be relatively stable
over time [77]. It has also been shown in the Women’s Health Initiative, where DII was measured
at different time points, that changes in DII towards a pro-inflammatory diets are associated with
an elevated risk of colon cancer [78]. Third, we observed substantial heterogeneity across studies
pooling the CRC risk. The probable reasons for this could be the differences in the number of food
parameters considered in the DII score in different studies, demographic characteristics, type of study,
and follow-up duration (in the case of prospective studies).
5. Conclusions
In conclusion, this meta-analysis suggests that a more pro-inflammatory diet, as estimated by
the higher DII score, was independently associated with an increased risk of CRC. Hence, promoting
diets low in pro-inflammatory items and rich in anti-inflammatory food components should help in
reducing the incidence of CRC. Future research should concentrate on how DII fares in a population
with CRC and what effect it would have on CRC-specific mortality.
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